omvoh

Generic: mirikizumab-mrkz

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name omvoh
Generic Name mirikizumab-mrkz
Labeler eli lilly and company
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

mirikizumab 100 mg/mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-8870
Product ID 0002-8870_e1015232-2dfd-4b5d-b1d0-e0302e49c55a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761279
Listing Expiration 2026-12-31
Marketing Start 2024-04-29

Pharmacologic Class

Established (EPC)
interleukin-23 antagonist [epc]
Mechanism of Action
interleukin-23 antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00028870
Hyphenated Format 0002-8870

Supplemental Identifiers

RxCUI
2668391 2668398 2668405 2668410 2680728 2680732 2703047 2703048 2703049 2703050 2703051 2703052 2703053 2703054
UNII
Z7HVY03PHP
NUI
N0000192799 N0000192798

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name omvoh (source: ndc)
Generic Name mirikizumab-mrkz (source: ndc)
Application Number BLA761279 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 mg/mL
source: ndc
Packaging
  • 2 SYRINGE in 1 CARTON (0002-8870-27) / 1 mL in 1 SYRINGE (0002-8870-01)
source: ndc

Packages (1)

0002-8870-27 2 SYRINGE in 1 CARTON (0002-8870-27) / 1 mL in 1 SYRINGE (0002-8870-01)

Ingredients (1)

mirikizumab (100 mg/mL)

Linked Drug Pages (1)

Omvoh ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "e1015232-2dfd-4b5d-b1d0-e0302e49c55a", "openfda": {"nui": ["N0000192799", "N0000192798"], "unii": ["Z7HVY03PHP"], "rxcui": ["2668391", "2668398", "2668405", "2668410", "2680728", "2680732", "2703047", "2703048", "2703049", "2703050", "2703051", "2703052", "2703053", "2703054"], "spl_set_id": ["472cbe04-263e-433d-9a0f-58c1b50b715a"], "pharm_class_epc": ["Interleukin-23 Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-23 Antagonists [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 CARTON (0002-8870-27)  / 1 mL in 1 SYRINGE (0002-8870-01)", "package_ndc": "0002-8870-27", "marketing_start_date": "20240429"}], "brand_name": "Omvoh", "product_id": "0002-8870_e1015232-2dfd-4b5d-b1d0-e0302e49c55a", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Interleukin-23 Antagonist [EPC]", "Interleukin-23 Antagonists [MoA]"], "product_ndc": "0002-8870", "generic_name": "mirikizumab-mrkz", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Omvoh", "active_ingredients": [{"name": "MIRIKIZUMAB", "strength": "100 mg/mL"}], "application_number": "BLA761279", "marketing_category": "BLA", "marketing_start_date": "20240429", "listing_expiration_date": "20261231"}